These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27861221)

  • 41. Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation.
    Böhm J; Yiş U; Ortaç R; Cakmakçı H; Kurul SH; Dirik E; Laporte J
    Orphanet J Rare Dis; 2010 Dec; 5():35. PubMed ID: 21129173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.
    Böhm J; Biancalana V; Dechene ET; Bitoun M; Pierson CR; Schaefer E; Karasoy H; Dempsey MA; Klein F; Dondaine N; Kretz C; Haumesser N; Poirson C; Toussaint A; Greenleaf RS; Barger MA; Mahoney LJ; Kang PB; Zanoteli E; Vissing J; Witting N; Echaniz-Laguna A; Wallgren-Pettersson C; Dowling J; Merlini L; Oldfors A; Bomme Ousager L; Melki J; Krause A; Jern C; Oliveira AS; Petit F; Jacquette A; Chaussenot A; Mowat D; Leheup B; Cristofano M; Poza Aldea JJ; Michel F; Furby A; Llona JE; Van Coster R; Bertini E; Urtizberea JA; Drouin-Garraud V; Béroud C; Prudhon B; Bedford M; Mathews K; Erby LA; Smith SA; Roggenbuck J; Crowe CA; Brennan Spitale A; Johal SC; Amato AA; Demmer LA; Jonas J; Darras BT; Bird TD; Laurino M; Welt SI; Trotter C; Guicheney P; Das S; Mandel JL; Beggs AH; Laporte J
    Hum Mutat; 2012 Jun; 33(6):949-59. PubMed ID: 22396310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation.
    Jungbluth H; Cullup T; Lillis S; Zhou H; Abbs S; Sewry C; Muntoni F
    Neuromuscul Disord; 2010 Jan; 20(1):49-52. PubMed ID: 19932620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myopathology of Congenital Myopathies: Bridging the Old and the New.
    Phadke R
    Semin Pediatr Neurol; 2019 Apr; 29():55-70. PubMed ID: 31060726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands.
    Reumers SFI; Erasmus CE; Bouman K; Pennings M; Schouten M; Kusters B; Duijkers FAM; van der Kooi A; Jaeger B; Verschuuren-Bemelmans CC; Faber CG; van Engelen BG; Kamsteeg EJ; Jungbluth H; Voermans NC
    Clin Genet; 2021 Dec; 100(6):692-702. PubMed ID: 34463354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and histologic findings in autosomal centronuclear myopathy.
    Jeannet PY; Bassez G; Eymard B; Laforêt P; Urtizberea JA; Rouche A; Guicheney P; Fardeau M; Romero NB
    Neurology; 2004 May; 62(9):1484-90. PubMed ID: 15136669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.
    Cowling BS; Chevremont T; Prokic I; Kretz C; Ferry A; Coirault C; Koutsopoulos O; Laugel V; Romero NB; Laporte J
    J Clin Invest; 2014 Mar; 124(3):1350-63. PubMed ID: 24569376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
    Jungbluth H; Zhou H; Sewry CA; Robb S; Treves S; Bitoun M; Guicheney P; Buj-Bello A; Bönnemann C; Muntoni F
    Neuromuscul Disord; 2007 Apr; 17(4):338-45. PubMed ID: 17376685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Respiratory assessment in centronuclear myopathies.
    Smith BK; Goddard M; Childers MK
    Muscle Nerve; 2014 Sep; 50(3):315-26. PubMed ID: 24668768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
    Tinelli E; Pereira JA; Suter U
    Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Common and variable clinical, histological, and imaging findings of recessive RYR1-related centronuclear myopathy patients.
    Abath Neto O; Moreno CAM; Malfatti E; Donkervoort S; Böhm J; Guimarães JB; Foley AR; Mohassel P; Dastgir J; Bharucha-Goebel DX; Monges S; Lubieniecki F; Collins J; Medne L; Santi M; Yum S; Banwell B; Salort-Campana E; Rendu J; Fauré J; Yis U; Eymard B; Cheraud C; Schneider R; Thompson J; Lornage X; Mesrob L; Lechner D; Boland A; Deleuze JF; Reed UC; Oliveira ASB; Biancalana V; Romero NB; Bönnemann CG; Laporte J; Zanoteli E
    Neuromuscul Disord; 2017 Nov; 27(11):975-985. PubMed ID: 28818389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New variant of necklace fibres display peculiar lysosomal structures and mitophagy.
    Rinnenthal JL; Dittmayer C; Irlbacher K; Wacker I; Schröder R; Goebel HH; Butori C; Villa L; Sacconi S; Stenzel W
    Neuromuscul Disord; 2018 Oct; 28(10):846-856. PubMed ID: 30149909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Congenital myopathies with secondary neuromuscular transmission defects; a case report and review of the literature.
    Rodríguez Cruz PM; Sewry C; Beeson D; Jayawant S; Squier W; McWilliam R; Palace J
    Neuromuscul Disord; 2014 Dec; 24(12):1103-10. PubMed ID: 25127990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model.
    Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M
    Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Respiratory features of centronuclear myopathy in the Netherlands.
    Bouma S; Cobben N; Bouman K; Gaytant M; van de Biggelaar R; van Doorn J; Reumers SFI; Voet NB; Doorduin J; Erasmus CE; Kamsteeg EJ; Jungbluth H; Wijkstra P; Voermans NC
    Neuromuscul Disord; 2023 Jul; 33(7):580-588. PubMed ID: 37364426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tamoxifen improves muscle structure and function of Bin1- and Dnm2-related centronuclear myopathies.
    Gineste C; Simon A; Braun M; Reiss D; Laporte J
    Brain; 2023 Jul; 146(7):3029-3048. PubMed ID: 36562127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Familial centronuclear myopathy: a clinical and pathological study.
    Sher JH; Rimalovski AB; Athanassiades TJ; Aronson SM
    Neurology; 1967 Aug; 17(8 Pt 1):727-42. PubMed ID: 15088533
    [No Abstract]   [Full Text] [Related]  

  • 58. Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.
    Tasfaout H; Lionello VM; Kretz C; Koebel P; Messaddeq N; Bitz D; Laporte J; Cowling BS
    Mol Ther; 2018 Apr; 26(4):1082-1092. PubMed ID: 29506908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extramuscular manifestations in children with severe congenital myopathy due to ACTA1 gene mutations.
    Saito Y; Komaki H; Hattori A; Takeuchi F; Sasaki M; Kawabata K; Mitsuhashi S; Tominaga K; Hayashi YK; Nowak KJ; Laing NG; Nonaka I; Nishino I
    Neuromuscul Disord; 2011 Jul; 21(7):489-93. PubMed ID: 21514153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibres due to a DNM2 mutation.
    Romero NB; Bevilacqua JA; Oldfors A; Fardeau M
    Neuromuscul Disord; 2011 Feb; 21(2):148; author reply 148-9. PubMed ID: 21247764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.